News – Page 124 – Endpoints News

George Church spinout raises $60M for protein therapies from genomically recoded organisms

10 months ago

Artiva's IPO raises $167M to fund company's autoimmune and cancer cell therapies

10 months ago

Ardelyx sues Medicare over attempt to change coverage for dialysis drug

10 months ago

Q&A: How argenx’s CEO plans to create a sequel to Vyvgart (and beat the IRA)

10 months ago

Aveo Oncology’s Fotivda combo fails in Phase 3 kidney cancer test

10 months ago

Novartis CEO: Trying to crack obesity market with another first-gen agent is 'not a prudent approach'

10 months ago

Boehringer plans to again increase R&D spending; Valneva, Pfizer to advance Lyme vaccine candidate

10 months ago

Catalent finishes German expansion; Grünenthal invests in Latin America

10 months ago

Parker Institute for Cancer Immunotherapy invests another $125M into research

10 months ago

J&J ditches epilepsy development with Addex, blindsiding 20-year partner

10 months ago

Sanofi seeks deeper roots in India with €400M hub expansion

10 months ago

Phathom wins label expansion on heartburn drug to include non-erosive patients

10 months ago

GoodRx launches discount for Boehringer Ingelheim's Humira biosimilar

10 months ago

Roche touts Phase 3 Susvimo data in diabetes-related ophthalmic diseases

10 months ago

KRAS cancer drug eased symptoms of rare and serious blood vessel condition in two patients, new study shows

10 months ago

Novartis settles in to new normal two years after big reorg, even as fine-tuning continues

10 months ago

FDA thwarts Agenus' accelerated approval plans for CTLA-4/PD-1 combo in 'disappointing' move

10 months ago

Exclusive: TMRW Life Sciences raises $28M Series D to upgrade storage for egg freezing

10 months ago

Merck asks DC federal court for IRA decision 'as soon as practicable'

10 months ago

J&J has its final offer in hand from the government over IRA pricing

10 months ago

FDA announces rare disease hub in bid to streamline treatment paths

10 months ago

Thyme Care scores $480M valuation in new funding round

10 months ago

Gilead chief medical officer Merdad Parsey to leave company early next year

10 months ago

Big three PBMs will testify before Congress next week, following FTC report

10 months ago

First page Previous page 121 122 123124125 126 127 Next page Last page